Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic

Παρόμοια τεκμήρια

• Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
  ανά: Simonini, Gabriele, κ.ά.
  Έκδοση: (2013)
• Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
  ανά: Giani, TG, κ.ά.
  Έκδοση: (2008)
• PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
  ανά: Moretti, D, κ.ά.
  Έκδοση: (2013)
• Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
  ανά: Simonini, Gabriele, κ.ά.
  Έκδοση: (2014)
• Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series
  ανά: Taddio, Andrea, κ.ά.
  Έκδοση: (2011)